Is Tattooing a Risk Factor for Hepatitis C Transmission?: An Updated Systematic Review and Meta-Analysis

Authors Information
Article Notes and Dates
To Cite : Khodadost M, Maajani K, Arabsalmani M, Mahdavi N, Tabrizi R, et al. Is Tattooing a Risk Factor for Hepatitis C Transmission?: An Updated Systematic Review and Meta-Analysis, Hepat Mon. 2017 ;17(9):e14308. doi: 10.5812/hepatmon.14308.
Copyright: Copyright © 2017, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Context
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Grumet GW. Psychodynamic implications of tattoos. Am J Orthopsychiatry. 1983; 53(3): 482-92[PubMed]
  • 2. Thomson W, McDonald JC. Self-tattooing by schoolchildren. Lancet. 1983; 2(8361): 1243-4[PubMed]
  • 3. Laumann AE, Derick AJ. Tattoos and body piercings in the United States: a national data set. J Am Acad Dermatol. 2006; 55(3): 413-21[DOI][PubMed]
  • 4. Deschesnes M, Demers S, Fines P. Prevalence and characteristics of body piercing and tattooing among high school students. Can J Public Health. 2006; 97(4): 325-9[PubMed]
  • 5. Jafari S, Copes R, Baharlou S, Etminan M, Buxton J. Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis. 2010; 14(11)-40[DOI][PubMed]
  • 6. Meyer RA, Gordon SC. Epidemiology of hepatitis C virus infection in a suburban Detroit community. Am J Gastroenterol. 1991; 86(9): 1224-6[PubMed]
  • 7. Esteban JI, Lopez-Talavera JC, Genesca J, Madoz P, Viladomiu L, Muniz E, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med. 1991; 115(6): 443-9[PubMed]
  • 8. Iwamura K, Pronai L, Nishioka K, Watanabe J. [Incidence of hepatitis C in chronic liver diseases following tattooing]. Orv Hetil. 1992; 133(15): 923-5[PubMed]
  • 9. Ko YC, Ho MS, Chiang TA, Chang SJ, Chang PY. Tattooing as a risk of hepatitis C virus infection. J Med Virol. 1992; 38(4): 288-91[PubMed]
  • 10. Memon MI, Memon MA. Hepatitis C: an epidemiological review. J Viral Hepat. 2002; 9(2): 84-100[PubMed]
  • 11. Karmochkine M, Carrat F, Dos Santos O, Cacoub P, Raguin G. A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection. J Viral Hepat. 2006; 13(11): 775-82[DOI][PubMed]
  • 12. Delarocque-Astagneau E, Pillonel J, De Valk H, Perra A, Laperche S, Desenclos JC. An incident case-control study of modes of hepatitis C virus transmission in France. Ann Epidemiol. 2007; 17(10): 755-62[DOI][PubMed]
  • 13. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005; 5(9): 558-67[DOI][PubMed]
  • 14. Birku T, Gelaw B, Moges F, Assefa A. Prevalence of hepatitis B and C viruses infection among military personnel at Bahir Dar Armed Forces General Hospital, Ethiopia. BMC Res Notes. 2015; 8: 737[DOI][PubMed]
  • 15. Nguyen LH, Nguyen MH. Systematic review: Asian patients with chronic hepatitis C infection. Aliment Pharmacol Ther. 2013; 37(10): 921-36[DOI][PubMed]
  • 16. Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002; 36(5 Suppl 1)-46[DOI][PubMed]
  • 17. Lee SS, Jeong SH, Jang ES, Kim YS, Lee YJ, Jung EU, et al. Prospective cohort study on the outcomes of hepatitis C virus-related cirrhosis in South Korea. J Gastroenterol Hepatol. 2015; 30(8): 1281-7[DOI][PubMed]
  • 18. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989; 2(8670): 1004-6[PubMed]
  • 19. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997; 349(9055): 825-32[PubMed]
  • 20. Alberti A, Chemello L, Benvegnu L. Natural history of hepatitis C. J Hepatol. 1999; 31 Suppl 1: 17-24[PubMed]
  • 21. Alter MJ, Margolis HS. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. 1998;
  • 22. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999; 341(8): 556-62[DOI][PubMed]
  • 23. Sun CA, Chen HC, Lu CF, You SL, Mau YC, Ho MS, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol. 1999; 59(3): 290-6[PubMed]
  • 24. Shin HR. Epidemiology of hepatitis C virus in Korea. Intervirology. 2006; 49(1-2): 18-22[DOI][PubMed]
  • 25. Kim YS, Ahn YO, Kim DW. A case-control study on the risk factors of hepatitis C virus infection among Koreans. J Korean Med Sci. 1996; 11(1): 38-43[DOI][PubMed]
  • 26. Hellard ME, Hocking JS, Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect. 2004; 132(3): 409-15[PubMed]
  • 27. Davis AR. Tattoo parlours and hepatitis C virus infection. Med J Aust. 1995; 163(10): 556-7[PubMed]
  • 28. Simonian PT, Gilbert M, Trumble TE. Incidence of hepatitis C in patients requiring orthopaedic surgery. J Bone Joint Surg Br. 1995; 77(6): 971-4[PubMed]
  • 29. Brind AM, Watson JP, James OF, Bassendine MF. Hepatitis C virus infection in the elderly. QJM. 1996; 89(4): 291-6[PubMed]
  • 30. Sun DX, Zhang FG, Geng YQ, Xi DS. Hepatitis C transmission by cosmetic tattooing in women. Lancet. 1996; 347(9000): 541[PubMed]
  • 31. Thompson SC, Hernberger F, Wale E, Crofts N. Hepatitis C transmission through tattooing: a case report. Aust N Z J Public Health. 1996; 20(3): 317-8[PubMed]
  • 32. Mele A, Corona R, Tosti ME, Palumbo F, Moiraghi A, Novaco F, et al. Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy. Scand J Infect Dis. 1995; 27(5): 441-4[PubMed]
  • 33. Kaldor JM, Archer GT, Buring ML, Ismay SL, Kenrick KG, Lien AS, et al. Risk factors for hepatitis C virus infection in blood donors: a case-control study. Med J Aust. 1992; 157(4): 227-30[PubMed]
  • 34. Parana R, Vitvitski L, Andrade Z, Trepo C, Cotrim H, Bertillon P, et al. Acute sporadic non-A, non-B hepatitis in Northeastern Brazil: etiology and natural history. Hepatology. 1999; 30(1): 289-93[DOI][PubMed]
  • 35. Kuberski T, LeGonidec G, Gust ID, Dimitrakakis M, Cantaloube D, Zimmet P. Hepatitis B virus infections in Melanesians and Polynesians in New Caledonia. Am J Epidemiol. 1981; 114(3): 355-61[PubMed]
  • 36. Tibbs CJ. Hepatitis B, tropical ulcers, and immunisation strategy in Kiribati. Br Med J (Clin Res Ed). 1987; 294(6571): 537-40[PubMed]
  • 37. Phoon WO, Fong NP, Lee J. History of blood transfusion, tattooing, acupuncture and risk of hepatitis B surface antigenaemia among Chinese men in Singapore. Am J Public Health. 1988; 78(8): 958-60[PubMed]
  • 38. Dufour A, Alary M, Poulin C, Allard F, Noel L, Trottier G, et al. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS. 1996; 10(9): 1009-15[PubMed]
  • 39. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med. 1996; 334(26): 1691-6[DOI][PubMed]
  • 40. Garner JJ, Gaughwin M, Dodding J, Wilson K. Prevalence of hepatitis C infection in pregnant women in South Australia. Med J Aust. 1997; 167(9): 470-2[PubMed]
  • 41. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology. 2000; 31(3): 756-62[DOI][PubMed]
  • 42. Tohme RA, Holmberg SD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis. 2012; 54(8): 1167-78[DOI][PubMed]
  • 43. Carney K, Dhalla S, Aytaman A, Tenner CT, Francois F. Association of tattooing and hepatitis C virus infection: a multicenter case-control study. Hepatology. 2013; 57(6): 2117-23[DOI][PubMed]
  • 44. Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health. 2000; 3(2): 121-6[PubMed]
  • 45. Crofts N, Stewart T, Hearne P, Ping XY, Breshkin AM, Locarnini SA. Spread of bloodborne viruses among Australian prison entrants. BMJ. 1995; 310(6975): 285-8[PubMed]
  • 46. Ruiz JD, Molitor F, Sun RK, Mikanda J, Facer M, Colford JJ, et al. Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system. West J Med. 1999; 170(3): 156-60[PubMed]
  • 47. Kondro W. Prison tattoo program wasn't given enough time. CMAJ. 2007; 176(3): 307-8[DOI][PubMed]
  • 48. Poulin C, Alary M, Lambert G, Godin G, Landry S, Gagnon H, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. CMAJ. 2007; 177(3): 252-6[DOI][PubMed]
  • 49. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med. 2007; 45(4): 247-51[DOI][PubMed]
  • 50. Akbari M, Moosazadeh M, Tabrizi R, Khatibi SR, Khodadost M, Heydari ST, et al. Estimation of iron deficiency anemia in Iranian children and adolescents: a systematic review and meta-analysis. Hematology. 2017; 22(4): 231-9
  • 51. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11): 1539-58[DOI][PubMed]
  • 52. Light RJ, Pillemer DB. Summing Up: The Science of Reviewing Research. 1984;
  • 53. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109): 629-34[PubMed]
  • 54. Roy E, Haley N, Leclerc P, Boivin JF, Cedras L, Vincelette J. Risk factors for hepatitis C virus infection among street youths. CMAJ. 2001; 165(5): 557-60[PubMed]
  • 55. Kim YS, Ahn YO, Lee HS. Risk factors for hepatitis C virus infection among Koreans according to the hepatitis C virus genotype. J Korean Med Sci. 2002; 17(2): 187-92[DOI][PubMed]
  • 56. Haley RW, Fischer RP. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore). 2001; 80(2): 134-51[PubMed]
  • 57. Post JJ, Dolan KA, Whybin LR, Carter IW, Haber PS, Lloyd AR. Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route. Med J Aust. 2001; 174(4): 183-4[PubMed]
  • 58. Nishioka S, Gyorkos TW. Tattoos as risk factors for transfusion-transmitted diseases. Int J Infect Dis. 2001; 5(1): 27-34[PubMed]
  • 59. Centers for Disease C. Methicillin-resistant Staphylococcus aureus skin infections among tattoo recipients--Ohio, Kentucky, and Vermont, 2004-2005. MMWR Morb Mortal Wkly Rep. 2006; 55(24): 677-9[PubMed]
  • 60. Ghorpade A. Inoculation (tattoo) leprosy: a report of 31 cases. J Eur Acad Dermatol Venereol. 2002; 16(5): 494-9[PubMed]
  • 61. Calzavara L, Ramuscak N, Burchell AN, Swantee C, Myers T, Ford P, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. CMAJ. 2007; 177(3): 257-61[DOI][PubMed]
  • 62. Backmund M, Meyer K, Wachtler M, Eichenlaub D. Hepatitis C virus infection in injection drug users in Bavaria: risk factors for seropositivity. Eur J Epidemiol. 2003; 18(6): 563-8[PubMed]
  • 63. Baillargeon J, Wu H, Kelley MJ, Grady J, Linthicum L, Dunn K. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health. 2003; 117(1): 43-8[PubMed]
  • 64. Burek V, Horvat J, Butorac K, Mikulic R. Viral hepatitis B, C and HIV infection in Croatian prisons. Epidemiol Infect. 2010; 138(11): 1610-20[DOI][PubMed]
  • 65. Robaeys G, Arain A, Stöver H. Emerging Issues in Prison Health. 2017; : 169-81
  • 66. Treloar C, McCredie L, Lloyd AR. The Prison Economy of Needles and Syringes: What Opportunities Exist for Blood Borne Virus Risk Reduction When Prices Are so High? PLoS One. 2016; 11(9)[DOI][PubMed]
  • 67. Kamynina E, Stover PJ. The Roles of SUMO in Metabolic Regulation. Adv Exp Med Biol. 2017; 963: 143-68[DOI][PubMed]
  • 68. Brinkley-Rubinstein L, Cloud DH, Davis C, Zaller N, Delany-Brumsey A, Pope L, et al. Addressing excess risk of overdose among recently incarcerated people in the USA: harm reduction interventions in correctional settings. Int J Prison Health. 2017; 13(1): 25-31[DOI][PubMed]
  • 69. Stöver H, Hariga F. Prison-based needle and syringe programmes (PNSP) – Still highly controversial after all these years. Drugs Educ Prevent Policy. 2016; 23(2): 103-12[DOI]
  • 70. Combating hepatitis B and C to reach elimination by 2030: advocacy brief. 2016;
  • 71. Jafari S, Buxton JA, Afshar K, Copes R, Baharlou S. Tattooing and risk of hepatitis B: a systematic review and meta-analysis. Can J Public Health. 2012; 103(3): 207-12[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check